Compositions and methods for inhibiting expression of the PCSK9 gene

Details for Australian Patent Application No. 2010241357 (hide)

Owner Alnylam Pharmaceuticals, Inc.

Inventors Tan, Pamela; Bramlage, Birgit; FrankKamenetsky, Maria; Fitzgerald, Kevin; Akinc, Akin; Kotelianski, Victor E.

Agent FB Rice

Pub. Number AU-B-2010241357

Parent 2007249329

Filing date 9 November 2010

Wipo publication date 2 December 2010

Acceptance publication date 13 September 2012

International Classifications

C12Q 1/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

A01N 43/04 Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/07

C07H 21/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C12N 15/113 Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

25 November 2010 Complete Application Filed

2 December 2010 Application Open to Public Inspection

  Published as AU-B-2010241357

13 September 2012 Application Accepted

  Published as AU-B-2010241357

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010241358-Improvements for fuel combustion

2010241356-5-Lipoxygenase-activating protein (FLAP) inhibitors